NCT03309722
Recruiting
Not Applicable
Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer
ConditionsColorectal Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Colorectal Cancer
- Sponsor
- University of Southampton
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- overall survival
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression
Detailed Description
Single centre observational cohort study Prospectively recruited patients biomarker evaluation and identification of novel biomarkers
Investigators
Eligibility Criteria
Inclusion Criteria
- •colorectal cancer
Exclusion Criteria
- •hereditary CRC; tumours with extensive necrosis
Outcomes
Primary Outcomes
overall survival
Time Frame: 5 years
disease free survival
Time Frame: 5 years
local recurrence
Time Frame: 5 years
distant recurrence
Time Frame: 5 years
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Molecular Characterisation of Colorectal Cancer Peritoneal MetastasesColorectal Cancer MetastaticNCT05513716The Christie NHS Foundation Trust200
Recruiting
Not Applicable
Molecular analysis of cancers in the large intestine in patients that use statins.Colorectal carcinoma, Statins/statines, BMP, SMAD4, chemopreventionNL-OMON25857one
Unknown
Not Applicable
Molecular Profiling of Colorectal CancerColorectal CancerColon CancerColon AdenocarcinomaNCT04863768Hellenic Cooperative Oncology Group300
Unknown
Not Applicable
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer MetastasisRectal CancerChemoradiationNCT02979795China Medical University Hospital50
Active, not recruiting
Not Applicable
Determining colorectal cancer features using a Rwandan population to lay a foundation and inform precise colorectal cancer clinical managementISRCTN36459506KU Leuven300